Mallinckrodt gets NDA for pain med approved; BIND Therapeutics begins lung cancer drug trial;

@FierceBiotech: ICYMI: Scripps spinout aTyr grabs $59M in venture deals with a public twist. Story | Follow @FierceBiotech

@RyanMFierce: Add Five Prime to the biotech IPO queue, hunting for $60M public debut with backers from Pfizer, GlaxoSmithKline. Report | Follow @RyanMFierce

@EmilyMFierce: FDA notes 'technical deficiencies' in Chelsea's drug filing. Article | Follow @EmilyMFierce

> The FDA has accepted a New Drug Application from Mallinckrodt ($MNK) for MNK-795, a controlled-release oral drug combo of oxycodone and acetaminophen to treat moderate to severe acute pain. Mallinckrodt uses Depomed's Acuform drug delivery technology. Release

> BIND Therapeutics has begun a Phase II clinical study of BIND-014, a therapy to treat patients with non-small cell lung cancer. Release

Medical Device News

@FierceMedDev: Check out last week's special report: Top 10 Med Tech Investments of Q2. Report | Follow @FierceMedDev

@MarkHFierce: ReVision optics closed $55M in new equity financing. Medical Device financing shows some signs of life. Release | Follow @MarkHFierce

@DamianFierce: Quintiles has signed up to help Ascendancy Healthcare cash in on the Chinese pharma boom. More | Follow @DamianFierce

 @MichaelGFierce: NeuroSigma to begin PhIII epilepsy device trial. Item | Follow @MichaelGFierce

> Siemens sacking CEO as bad bets raid revenue. Report

> Glass implant envisioned to promote leg, arm bone repairs. More

> J&J leads ReVision Optics' $55M financing round. Story

Pharma News

@FiercePharma: Pfizer to split operations three ways. Story | Follow @FiercePharma

@EricPFierce: EU doesn't like smell of Germany's exemption to financially struggling drugmakers from paying drug rebates. More | Follow @EricPFierce

@CarlyHFierce: 's former head of China biz will be returning to China to assist with bribery probe. 18 more reportedly detained there. Article | Follow @CarlyHFierce

> Valeant to fire thousands, restructure ops after Bausch buyout. Report

> U.S. court upturns Teva's patents on cash-cow Copaxone. News

> OTC specialist Perrigo nabs Elan and its tax rate for $8.6B. Article

CRO News

> Swiss CRO Psi reaches into South Africa. Item

> Quintiles teams up with Ascendancy in China. News

> Icon ticks up guidance as revenue leaps another 21%. Report

> CRA buys Comprehensive Clinical's late-phase biz. Article

> AMRI working to get out from under FDA warning. More

Biotech IT News

> Medidata shares soar on another record quarter in Q2. Item

> AstraZeneca adds software from Dotmatics to virtual neuroscience group. Article

> Novo Nordisk among latest to join pharma flock on Twitter. Story

> Sanofi returns to the crowdsourcing well for diabetes app. More

> NIH earmarks $96M for multiyear effort to maximize value of Big Data. Report

And Finally... New research suggests that it may be possible for people to recover from autism. Story